Efficacy and Safety of Liver Chemoembolization Procedures, Combined with FOLFIRI Chemotherapy, in First-Line Treatment of Metastatic Colorectal Cancer in Patients with Oncogene Mutations.
Marcin SzemitkoAleksander FalkowskiModrzejewska MonikaElzbieta Golubinska-SzemitkoPublished in: Cancers (2023)
Combining FOLFIRI chemotherapy with chemoembolization procedures for liver metastatic lesions from colorectal cancer may provide a valuable treatment option for patients not qualified for monoclonal antibody therapy.
Keyphrases
- metastatic colorectal cancer
- monoclonal antibody
- end stage renal disease
- ejection fraction
- newly diagnosed
- squamous cell carcinoma
- small cell lung cancer
- locally advanced
- chronic kidney disease
- radiofrequency ablation
- prognostic factors
- peritoneal dialysis
- stem cells
- wild type
- bone marrow
- rectal cancer
- patient reported
- cell therapy
- replacement therapy